Ozempic® (Semaglutide Injection) – 0.25 mg | 0.5 mg | 1 mg | 2 mg

Ozempic® Injection (Semaglutide)

Ozempic® is a once-weekly injectable medicine containing Semaglutide, a GLP-1 receptor agonist used for the treatment of type 2 diabetes mellitus and widely prescribed for weight management.

Ozempic works by improving blood sugar control, reducing appetite, slowing gastric emptying, and supporting healthy weight loss when combined with diet and lifestyle changes.

It is globally trusted and manufactured by Novo Nordisk, making it one of the highest-demand injectable therapies worldwide.

Available Strengths

• Ozempic 0.25 mg Injection (starter dose)

• Ozempic 0.5 mg Injection

• Ozempic 1 mg Injection

• Ozempic 2 mg Injection

(All strengths supplied under the same product listing)

 Key Benefits

• Once-weekly dosing

• Improves glycemic control

• Supports weight reduction

• Reduces appetite and cravings

• Clinically proven GLP-1 therapy

 Indications

• Type 2 Diabetes Mellitus

• Weight Management (as prescribed)

• Metabolic health improvement

 Dosage & Administration

Ozempic is administered as a subcutaneous injection once weekly.
Dosage should be decided strictly by a qualified healthcare professional.

Export & Supply Information (B2B)

• Available for international export

• Cold-chain compliant packaging

• Batch-wise COA available on request

• Bulk & regular supply options

• Enquiry-based pricing

⚠ Prescription-only medicine. Not for self-medication.